SAVA Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges SAVA Investors With Losses to Contact the FirmSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
SAVA Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges SAVA Investors With Losses to Contact the FirmRADNOR, PA - (NewMediaWire) - January 4, 2025 - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Western District of Texas against Cassava Sciences, Inc. (“Cassava”) (
NASDAQSAVA) on behalf of those who purchased or otherwise acquired Cassava securities between February 7, 2024, and November 24, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 10, 2025.
Robbins LLP Reminds Investors of the Cassava Sciences, Inc. (SAVA) Class Action and Urges Investors with Large Losses to Contact the Firm for InformationSAN DIEGO, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed against Cassava Sciences, Inc. (
NASDAQSAVA) for wrongdoing between February 7, 2024 and November 24, 2024. Cassava is a clinical stage biotechnology company, with a focus on developing drugs for neurodegenerative diseases.
DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors of Cassava to Contact Us to Have Their Losses Evaluated TodayFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Cassava To Contact Him Directly To Discuss Their Options
Class Action Announcement (SAVA): A Securities Fraud Class Action Lawsuit Was Filed Against Cassava Sciences, Inc. (SAVA)Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
SAVA Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Cassava Sciences, Inc.
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava”) (
NASDAQSAVA) on behalf of those who purchased or otherwise acquired Cassava securities between February 7, 2024, and November 24, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 10, 2025.
SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava” or “the Company”) (
NASDAQSAVA) and certain of its officers.
CASSAVA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Cassava Sciences, Inc and Encourages Investors to Contact the FirmNEW YORK, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Cassava Sciences, Inc (“Cassava” or the “Company”) (
NASDAQSAVA) in the United States District Court for the Western District of Texas on behalf of all persons and entities who purchased or otherwise acquired Cassava securities between February 7, 2024 to November 24, 2024, both dates inclusive (the “Class Period”). Investors have until February 10, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CassavaFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Cassava To Contact Him Directly To Discuss Their Options
Cassava Sciences, Inc. Stockholder Alert: Robbins LLP Reminds Investors of the SAVA Class ActionSAN DIEGO, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed against Cassava Sciences, Inc. (
NASDAQSAVA) for wrongdoing between February 7, 2024 and November 24, 2024. Cassava is a clinical stage biotechnology company, with a focus on developing drugs for neurodegenerative diseases.
SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava” or “the Company”) (
NASDAQSAVA) and certain of its officers.
CASSAVA SCIENCES, INC. (NASDAQ: SAVA) INVESTOR ALERT: Investors With Large Losses in Cassava Sciences, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their RightsNEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Cassava Sciences, Inc. (“Cassava” or the “Company”) (
NASDAQSAVA) between February 7, 2024 and November 24, 2024, inclusive.
CASSAVA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Cassava Sciences, Inc and Encourages Investors to Contact the FirmNEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Cassava Sciences, Inc (“Cassava” or the “Company”) (
NASDAQSAVA) in the United States District Court for the Western District of Texas on behalf of all persons and entities who purchased or otherwise acquired Cassava securities between February 7, 2024 to November 24, 2024, both dates inclusive (the “Class Period”). Investors have until February 10, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Class Action Filed Against Cassava Sciences, Inc. (SAVA) - February 10, 2025 Deadline to Join - Contact Levi & KorsinskyNEW YORK, NY / ACCESSWIRE / December 17, 2024 / If you suffered a loss on your Cassava Sciences, Inc. (
NASDAQSAVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Investors who lost money on Cassava Sciences, Inc.(SAVA) should contact Levi & Korsinsky about pending Class Action - SAVANEW YORK, NY / ACCESSWIRE / December 16, 2024 / If you suffered a loss on your Cassava Sciences, Inc. (
NASDAQSAVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Lost Money on Cassava Sciences, Inc.(SAVA)? Join Class Action Suit Seeking Recovery – Contact Levi & KorsinskyNEW YORK, NY / ACCESSWIRE / December 16, 2024 / If you suffered a loss on your Cassava Sciences, Inc. (
NASDAQSAVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Cassava Sciences, Inc.(SAVA) ShareholdersNEW YORK, NY / ACCESSWIRE / December 16, 2024 / If you suffered a loss on your Cassava Sciences, Inc. (
NASDAQSAVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Contact Levi & Korsinsky by February 10, 2025 Deadline to Join Class Action Against Cassava Sciences, Inc. (SAVA)NEW YORK, NY / ACCESSWIRE / December 16, 2024 / If you suffered a loss on your Cassava Sciences, Inc. (
NASDAQSAVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Shareholders that Lost Money on Cassava Sciences, Inc. (SAVA) Should Contact Levi & Korsinsky About Pending Class Action - SAVANEW YORK, NY / ACCESSWIRE / December 16, 2024 / If you suffered a loss on your Cassava Sciences, Inc. (
NASDAQSAVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
